Sotatercept May Reach Beyond Pulmonary Hypertension Into Heart Failure and Transplant Care
An opinion article argues that the activin-trap drug sotatercept, proven in pulmonary arterial hypertension and supported by the CADENCE trial ...
An opinion article argues that the activin-trap drug sotatercept, proven in pulmonary arterial hypertension and supported by the CADENCE trial ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.